Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats

Journal of Pharmacological Sciences

Volumn 119, Issue 2, 2012, Pages 167-176

  Luan, Jiajie ^a,b   Li, Weiping ^a,d   Han, Jia ^a   Zhang, Wen ^b   Gong, Huiling ^a   Ma, Rong ^c,d  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Yijishan Hospital of Wannan Medical University   (China)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d Anqing Medical and Pharmaceutical College ^*  (China)

Author keywords

Collagen IV; Diabetic nephropathy; Tempol; Transient receptor potential 6 (TRPC6)

Indexed keywords

COLLAGEN TYPE 4; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MESSENGER RNA; NITROGEN; SUPEROXIDE DISMUTASE; TEMPOL; TRANSFORMING GROWTH FACTOR BETA1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UREA;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME ACTIVITY; FOOD INTAKE; HISTOPATHOLOGY; IN VIVO STUDY; KIDNEY FUNCTION; MALE; METABOLIC PARAMETERS; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UPREGULATION; URINE VOLUME;

EID: 84863083735     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12002FP     Document Type: Article

References (57)

1. Ibrahim HN, Hostetter TH. Diabetic nephropathy. J Am Soc Nephrol. 1997;8:487-493. (Pubitemid 127454185)
2. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH. Glomerular structure and function in proteinuric type 2 (non-insulin dependent) diabetic patients. Diabetologia. 1993; 36:1064-1070. (Pubitemid 23288777)
3. Choudhury D, Tuncel M, Levi M. Diabetic nephropathy - a multifaceted target of new therapies. Discov Med. 2010;10: 406-415.
4. Brindeiro CMT, Fallet RW, Lane PH, Carmines PK. Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney. Am J Physiol Renal Physiol. 2008; 295:F171-F178.
5. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Shigeta Y. Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: a possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophysic Res Commun. 1986;136:1185-1190. (Pubitemid 16066757)
6. Menè P, Pascale C, Teti A, Bernardini SV, Cinotti GA, Pugliese F. Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells. J Am Soc Nephrol. 1999;10:1478-1486. (Pubitemid 29297522)
7. Nutt LK, O'Neil RG. Effect of elevated glucose on endothelininduced store-operated and non-store-operated calcium influx in renal mesangial cells. J Am Soc Nephrol. 2000;11:1225-1235. (Pubitemid 30416218)
8. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev. 1998; 78:723-744. (Pubitemid 28340601)
9. Whiteside CI, Hurst RD, Stevanovic ZS. Calcium signaling and contractile response of diabetic glomerular mesangial cells. Kidney Int Suppl. 1995;51:S28-S33.
10. Horinouchi T, Terada K, Higa T, Aoyagi H, Nishiya T, Suzuki H, et al. Function and regulation of endothelin type A receptor-oper ated transient receptor potential canonical channels. J Pharmacol Sci. 2011;117:295-306.
11. Bush EW, Hood DB, Papst PJ, Chapo JA, Minobe W, Bristow MR, et al. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J Biol Chem. 2006;281:33487-33496. (Pubitemid 46036730)
12. Facemire CS, Mohler PJ, Arendshorst WJ. Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation. Am J Physiol Renal Physiol. 2004;286:F546-F551. (Pubitemid 38233649)
13. Du J, Sours-Brothers S, Coleman R, Ding M, Graham S, Kong D, et al. TRPC1 channel is involved in contractile function of glomerular mesangial cells. J Am Soc Nephrol. 2007;18: 1437-1445. (Pubitemid 46717510)
14. Sours S, Du J, Chu S, Ding M, Zhou XJ, Ma R. Expression of canonical transient receptor potential (TRPC) proteins in human glomerular mesangial cells. Am J Physiol Renal Physiol. 2006;290:F1507-F1515. (Pubitemid 43830778)
15. Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, et al. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol. 2011;301:C304-C315.
16. Du J, Ding M, Sours-Brothers S, Graham S, Ma R. Mediation of angiotensin II-induced Ca2+ signaling by polycystin 2 in glomerular mesangial cells. Am J Physiol Renal Physiol. 2008;294: F909-F918.
17. 2+ signaling in glomerular mesangial cells in diabetes. Am J Physiol Renal Physiol. 2007; 293:1381-1390.
18. Yin X, Zhang Y, Yu J, Zhang P, Shen J, Qiu J, et al. The antioxidative effects of astragalus saponin I protect against development of early diabetic nephropathy. J Pharmacol Sci. 2006;101: 166-173. (Pubitemid 43938768)
19. Yin X, Zhang Y, Wu H, Zhu X, Zheng X, Jiang S, et al. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci. 2004;95:256-266. (Pubitemid 38899696)
20. Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am. 2004;88:947-999, xi. (Pubitemid 39090347)
21. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24-38. (Pubitemid 36410972)
22. 2-), superoxide dismutases, and related matters. J Biol Chem. 1997;272: 18515-18517.
23. Sindhu RK, Koo JR, Roberts CK, Vaziri ND. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin Exp Hypertens. 2004;26:43-53. (Pubitemid 38248221)
24. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membranepermeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64. (Pubitemid 28324125)
25. Schnackenberg CG, Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int. 2001;59:1859-1864. (Pubitemid 32336801)
26. Patel NS, Chatterjee PK, Chatterjee BE, Cuzzocrea S, Serraino I, Brown PA, et al. TEMPONE reduces renal dysfunction and injury mediated by oxidative stress of the rat kidney. Free Radic Biol Med. 2002;33:1575-1589. (Pubitemid 35351601)
27. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, et al. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol. 2004;15: 306-315. (Pubitemid 38140771)
28. Matsumoto T, Ono Y, Kurono M, Kuromiya A, Nakamura K, Bril V. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux. J Pharmacol Sci. 2009;109:203-210.
29. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17: 4256-4269.
30. Wu Y, Ren K, Liang C, Yuan L, Qi X, Dong J, et al. Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes. J Pharmacol Sci. 2009;109:78-87.
31. Busch M, Franke S, Rüster C, Wolf G. Advanced glycation endproducts and the kidney. Eur J Clin Invest. 2010;40:742-755.
32. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058-1070.
33. Evans JL, Goldfine D, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599-622. (Pubitemid 35191625)
34. Li J-M, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S221-S226. (Pubitemid 36903929)
35. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S241-S245. (Pubitemid 36903933)
36. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599-622. (Pubitemid 35191625)
37. Majid DS, Nishiyama A, Jackson KE, Castillo A. Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs. Am J Physiol Renal Physiol. 2005;288:F412-F419. (Pubitemid 40105401)
38. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of salt load-induced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res. 2001;24:127-135. (Pubitemid 32377583)
39. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes. 2003;52:846-851. (Pubitemid 36323595)
40. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97-112.
41. Kedziora-Kornatowska K, Szram S, Kornatowski T, Szadujkis-Szadurski L, Kedziora J, Bartosz G. The effect of verapamil on the antioxidant defence system in diabetic kidney. Clin Chim Acta. 2002;322:105-112. (Pubitemid 34718069)
42. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol. 2003;14: S250-S253. (Pubitemid 36903935)
43. Chaudhry J, Ghosh NN, Roy K, Chandra R. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sci. 2007;80:1135-1142. (Pubitemid 46241223)
44. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci U S A. 2000;97:8015-8020. (Pubitemid 30460765)
45. Isono M, Mogyorósi A, Han DC, Hoffman BB, Ziyadeh FN. Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol Renal Physiol. 2000;278:F830-F838. (Pubitemid 30351086)
46. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest. 1994;93:536-542. (Pubitemid 24072793)
47. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A. 1993;90:1814-1818. (Pubitemid 23069947)
48. Jiang W, Zhang Y, Wu H, Zhang X, Gan H, Sun J, et al. Role of cross-talk between the Smad 2 and MAPK pathways in TGF-beta1-induced collagen IV expression in mesangial cells. Int J Mol Med. 2010;26:571-576.
49. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, et al. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 1994; 43:478-490. (Pubitemid 24064258)
50. Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes. 2007;115:69-84. (Pubitemid 46408113)
51. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int. 2001;59:87-95. (Pubitemid 32055217)
52. Jiang Z, Seo JY, Ha H, Lee EA, Kim YS, Han DC, et al. Reactive oxygen species mediate TGF-beta1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem Biophys Res Commun. 2003;309:961-966. (Pubitemid 37122623)
53. Nishibayashi S, Hattori K, Hirano T, Uehara K, Nakano Y, Aihara M, et al. Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain. Exp Anim. 2010;59:157-170.
54. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens. 2005;18:707-713. (Pubitemid 40692440)
55. Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, et al. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant. 2011;26:2119-2126.
56. Dietrich A, Gudermann T. TRPC6. Handb Exp Pharmacol. 2007; 179:125-141.
57. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, et al. TRPC6 is a glomerular slit diaphram-associated channel required for normal renal function. Nat Genet. 2005;37: 739-744. (Pubitemid 41754891)